1961 related articles for article (PubMed ID: 7889291)
1. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
Löscher W; Hönack D
Br J Pharmacol; 1994 Dec; 113(4):1349-57. PubMed ID: 7889291
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models.
Yamaguchi S; Donevan SD; Rogawski MA
Epilepsy Res; 1993 Jul; 15(3):179-84. PubMed ID: 7693450
[TBL] [Abstract][Full Text] [Related]
3. The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors.
Block F; Schwarz M
Eur J Pharmacol; 1994 Apr; 256(2):149-53. PubMed ID: 8050465
[TBL] [Abstract][Full Text] [Related]
4. Anticonvulsant effect of flutamide on seizures induced by pentylenetetrazole: involvement of benzodiazepine receptors.
Ahmadiani A; Mandgary A; Sayyah M
Epilepsia; 2003 May; 44(5):629-35. PubMed ID: 12752460
[TBL] [Abstract][Full Text] [Related]
5. The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.
Chapman AG; Smith SE; Meldrum BS
Epilepsy Res; 1991 Jul; 9(2):92-6. PubMed ID: 1794356
[TBL] [Abstract][Full Text] [Related]
6. The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam.
Borowicz KK; Kleinrok Z; Czuczwar SJ
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):629-35. PubMed ID: 10882038
[TBL] [Abstract][Full Text] [Related]
7. Long-term studies on anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. I. Comparison of diazepam, clonazepam, clobazam and abecarnil.
Löscher W; Rundfeldt C; Hönack D; Ebert U
J Pharmacol Exp Ther; 1996 Nov; 279(2):561-72. PubMed ID: 8930158
[TBL] [Abstract][Full Text] [Related]
8. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice.
Czuczwar SJ; Borowicz KK; Kleinrok Z; Tutka P; Zarnowski T; Turski WA
Eur J Pharmacol; 1995 Aug; 281(3):327-33. PubMed ID: 8521917
[TBL] [Abstract][Full Text] [Related]
9. Anticonvulsant effects of thymoquinone, the major constituent of Nigella sativa seeds, in mice.
Hosseinzadeh H; Parvardeh S
Phytomedicine; 2004 Jan; 11(1):56-64. PubMed ID: 14971722
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant Activity of Essential Oil From Leaves of Zhumeria majdae (Rech.) in Mice: The Role of GABA
Aghamiri H; Shafaroodi H; Asgarpanah J
Clin Transl Sci; 2020 Jul; 13(4):785-797. PubMed ID: 32027449
[TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
Swedberg MD; Jacobsen P; Honoré T
J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
Löscher W; Nolting B; Hönack D
Eur J Pharmacol; 1988 Jul; 152(1-2):9-17. PubMed ID: 3061831
[TBL] [Abstract][Full Text] [Related]
13. The influence of the benzodiazepine receptor antagonist flumazenil on the anxiolytic-like effects of CGP 37849 and ACPC in rats.
Przegaliński E; Tatarczyńska E; Chojnacka-Wójcik E
Neuropharmacology; 2000 Jul; 39(10):1858-64. PubMed ID: 10884566
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute and repeated zolpidem treatment on pentylenetetrazole-induced seizure threshold and on locomotor activity: comparison with diazepam.
Vlainić J; Pericić D
Neuropharmacology; 2009 Jun; 56(8):1124-30. PubMed ID: 19345234
[TBL] [Abstract][Full Text] [Related]
15. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy.
Smith SE; Dürmüller N; Meldrum BS
Eur J Pharmacol; 1991 Aug; 201(2-3):179-83. PubMed ID: 1686756
[TBL] [Abstract][Full Text] [Related]
16. Anti-Seizure Activity of 1-Adamantane Carboxylic Acid in Common Experimental Seizure Models: Role of Benzodiazepine-GABAA Receptors.
Ghanbari E; Gavzan H; Khoshkroodian B; Sayyah M
Iran Biomed J; 2021 May; 25(3):213-9. PubMed ID: 33653022
[TBL] [Abstract][Full Text] [Related]
17. beta-Adrenoceptor blockade enhances the anticonvulsant effect of glutamate receptor antagonists against maximal electroshock.
Luchowska E; Luchowski P; Wielosz M; Kleinrok Z; Urbanska EM
Eur J Pharmacol; 2001 Nov; 431(2):209-14. PubMed ID: 11728427
[TBL] [Abstract][Full Text] [Related]
18. Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents.
Ferreri G; Chimirri A; Russo E; Gitto R; Gareri P; De Sarro A; De Sarro G
Pharmacol Biochem Behav; 2004 Jan; 77(1):85-94. PubMed ID: 14724045
[TBL] [Abstract][Full Text] [Related]
19. Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents.
De Sarro G; Ferreri G; Gareri P; Russo E; De Sarro A; Gitto R; Chimirri A
Pharmacol Biochem Behav; 2003 Feb; 74(3):595-602. PubMed ID: 12543224
[TBL] [Abstract][Full Text] [Related]
20. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.
Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V
J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
